相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Distribution of microglia in the postnatal murine nigrostriatal system
Ahmed Sharaf et al.
CELL AND TISSUE RESEARCH (2013)
Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease
Angelique Virgone-Carlotta et al.
GLIA (2013)
Knocking Out DJ-1 Attenuates Astrocytes Neuroprotection Against 6-Hydroxydopamine Toxicity
Nirit Lev et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion
Helena W. Morrison et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Foxa1 and Foxa2 Are Required for the Maintenance of Dopaminergic Properties in Ventral Midbrain Neurons at Late Embryonic Stages
Simon R. W. Stott et al.
JOURNAL OF NEUROSCIENCE (2013)
Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model
Hideaki Kabuto et al.
JOURNAL OF OLEO SCIENCE (2013)
Cell intrinsic and extrinsic factors contribute to enhance neural circuit reconstruction following transplantation in Parkinsonian mice
Jessica Kauhausen et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Probucol Affords Neuroprotection in a 6-OHDA Mouse Model of Parkinson's Disease
Renata Pietsch Ribeiro et al.
NEUROCHEMICAL RESEARCH (2013)
Activation of GSK-3β and Caspase-3 Occurs in Nigral Dopamine Neurons during the Development of Apoptosis Activated by a Striatal Injection of 6-Hydroxydopamine
Daniel Hernandez-Baltazar et al.
PLOS ONE (2013)
Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease
Aaron Kucinski et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
The genetics and neuropathology of Parkinson's disease
Henry Houlden et al.
ACTA NEUROPATHOLOGICA (2012)
Expression Analysis of Aldehyde Dehydrogenase 1A1 (ALDH1A1) in Colon and Rectal Cancer in Association with Prognosis and Response to Chemotherapy
Christoph Kahlert et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: Motor impairments identify extent of dopamine depletion at three different lesion sites
Andreas Heuer et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons
M. Decressac et al.
NEUROBIOLOGY OF DISEASE (2012)
Activating transcription factor 3 and the nervous system
David Hunt et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Biochemical Specificity of von Economo Neurons in Hominoids
Cheryl D. Stimpson et al.
AMERICAN JOURNAL OF HUMAN BIOLOGY (2011)
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
Susan Duty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models
Andrii Domanskyi et al.
FASEB JOURNAL (2011)
6-OHDA generated ROS induces DNA damage and p53-and PUMA-dependent cell death
Alison I. Bernstein et al.
MOLECULAR NEURODEGENERATION (2011)
TIME-COURSE OF NIGROSTRIATAL NEURODEGENERATION AND NEUROINFLAMMATION IN THE 6-HYDROXYDOPAMINE-INDUCED AXONAL AND TERMINAL LESION MODELS OF PARKINSON'S DISEASE IN THE RAT
S. Walsh et al.
NEUROSCIENCE (2011)
Systems Analysis of ATF3 in Stress Response and Cancer Reveals Opposing Effects on Pro-Apoptotic Genes in p53 Pathway
Yujiro Tanaka et al.
PLOS ONE (2011)
Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease
G. Ambrosi et al.
BRAIN RESEARCH BULLETIN (2010)
Cytoplasmic Mislocalization of the Orphan Nuclear Receptor Nurr1 Is a Prognostic Factor in Bladder Cancer
Teruo Inamoto et al.
CANCER (2010)
Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease
Shane Grealish et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP
Michela Di Salvio et al.
NATURE NEUROSCIENCE (2010)
Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson's Disease
Sang J. Na et al.
NEUROCHEMICAL RESEARCH (2010)
Expression of stress-response ATF3 is mediated by Nrf2 in astrocytes
Kyu-Han Kim et al.
NUCLEIC ACIDS RESEARCH (2010)
Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain
Lachlan H. Thompson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease
Lilia Marinova-Mutafchieva et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons
Banafsheh Kadkhodaei et al.
JOURNAL OF NEUROSCIENCE (2009)
Selective Deletion of PTEN in Dopamine Neurons Leads to Trophic Effects and Adaptation of Striatal Medium Spiny Projecting Neurons
Oscar Diaz-Ruiz et al.
PLOS ONE (2009)
Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat
Shane Grealish et al.
BRAIN RESEARCH BULLETIN (2008)
Differential activation of PKCδ in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesions
Katharine Hanrott et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylation and activation transcription factor 3 expression
Dae Y. Song et al.
EXPERIMENTAL NEUROLOGY (2008)
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice
Daniel Alvarez-Fischer et al.
EXPERIMENTAL NEUROLOGY (2008)
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice
Clare L. Parish et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3
Allison D. Ebert et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo
D. Moses et al.
NEUROSCIENCE (2008)
Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease
Thomas Carlsson et al.
JOURNAL OF NEUROSCIENCE (2007)
Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency
Frank M. J. Jacobs et al.
DEVELOPMENT (2007)
Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model
Fabio Blandini et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Transcriptional control of midbrain dopaminergic neuron development
Siew-Lan Ang
DEVELOPMENT (2006)
Up-regulation of microglial CD11b expression by nitric oxide
Avik Roy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
FA Perez et al.
BMC NEUROSCIENCE (2005)
Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections
L Thompson et al.
JOURNAL OF NEUROSCIENCE (2005)
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease
I Mendez et al.
BRAIN (2005)
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice
R Iancu et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death
WA Holtz et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice
SI Iwata et al.
SYNAPSE (2004)
Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes
C Wolfrum et al.
NATURE (2004)
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function
M Lundblad et al.
NEUROBIOLOGY OF DISEASE (2004)
Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease
AM Depino et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease
LA Cunningham et al.
EXPERIMENTAL NEUROLOGY (2002)
Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease
D Kirik et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Lentiviral vectors as a gene delivery system in the mouse midbrain:: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF
JC Bensadoun et al.
EXPERIMENTAL NEUROLOGY (2000)
Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model
C Rosenblad et al.
EXPERIMENTAL NEUROLOGY (2000)
分享论文
